To Evaluate the Impact of Treatment Interruption on Re-Initiation of Bifeprunox

This study has been completed.

Sponsor:

Collaborators:

H. Lundbeck A/S

Wyeth is now a wholly owned subsidiary of Pfizer

Information provided by:

Solvay Pharmaceuticals

ClinicalTrials.gov Identifier:

NCT00141479

First received: August 30, 2005

Last updated: May 5, 2006

Last verified: May 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given